The Clorox Company
CLX NYSEConsumer Defensive ★★★★★Latest Earnings
Date
Aug 3, 2026
ET
EPS Est.
1.64
EPS Actual
1.66
Revenue Est.
$1.91B
Revenue Actual
$1.95B
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
After-market
Fiscal Period
FY2027 Q1
EPS Est.
1.11
Revenue Est.
$1.88B
Company Overview
The Clorox Company (ticker CLX) is listed on NYSE with a market cap of about $12.9B. Its next earnings report (FY2027 Q1) is expected on Nov 3, 2026 (ET), After-market, with consensus EPS of 1.11. In the last 15 reported quarters, EPS beat consensus estimates 13 times.
Actual EPS TrendRecently15Term · Feb 2, 2023 → Aug 3, 2026
Feb 2, 2023Range: 0.49 ~ 2.87Aug 3, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 3, 2026 | -- | 1.64 | 1.66 | $1.91B | $1.95B |
| Apr 30, 2026 | -- | 1.55 | 1.64 | $1.67B | $1.67B |
| Feb 3, 2026 | -- | 1.43 | 1.39 | $1.64B | $1.67B |
| Nov 3, 2025 | -- | 0.82 | 0.85 | $1.4B | $1.43B |
| Jul 31, 2025 | -- | 2.20 | Above forecast↑2.87 | $1.93B | $1.99B |
| May 5, 2025 | -- | 1.55 | 1.45 | $1.72B | $1.67B |
| Feb 3, 2025 | -- | 1.39 | 1.55 | $1.76B | $1.69B |
| Oct 30, 2024 | -- | 1.41 | Above forecast↑1.86 | $1.65B | $1.76B |
| Aug 1, 2024 | -- | 1.56 | Above forecast↑1.82 | $1.95B | $1.9B |
| Apr 30, 2024 | -- | 1.36 | Above forecast↑1.71 | $1.87B | $1.81B |
| Feb 1, 2024 | -- | 1.08 | Above forecast↑2.16 | $1.8B | $1.99B |
| Nov 1, 2023 | -- | -0.20 | Above forecast↑0.49 | $1.31B | $1.39B |
| Aug 2, 2023 | -- | 1.18 | Above forecast↑1.67 | $1.88B | $2.02B |
| May 2, 2023 | -- | 1.20 | Above forecast↑1.51 | $1.82B | $1.92B |
| Feb 2, 2023 | -- | 0.65 | Above forecast↑0.98 | $1.66B | $1.72B |
Original Filings (SEC)
10-K2026-08-07 ↗
8-K2026-08-03 ↗
8-K2026-06-17 ↗
8-K2026-05-28 ↗
8-K2026-05-11 ↗
10-Q2026-04-30 ↗
8-K2026-04-30 ↗
8-K2026-04-01 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
